Great achievements, how does watson biological match the soaring share price?

Stock speculation is the expectation of speculation. Although watson biological lost 20 17, it has turned the corner. The domestic vaccine industry is developing well. The sales volume of the company's original self-produced vaccine products resumed growth, and the income increased substantially. At the same time, the company's new product, 23-valent pneumococcal polysaccharide vaccine, has been successfully listed and achieved good results. 1 quarterly profit increased year-on-year 18 1%.

In recent months, several well-known brokers have also given watson biological a good rating. Dongxing Securities, Founder Securities and China Merchants Securities are strongly recommended respectively; Southwest Securities and Bohai Securities suggest buying; Oriental fortune securities also gave an overweight rating. The above factors stimulated the stock price to soar.